Cargando…
Obesity and Type 2 Diabetes: Adiposopathy as a Triggering Factor and Therapeutic Options
Obesity and type 2 diabetes (T2DM) are major public health concerns associated with serious morbidity and increased mortality. Both obesity and T2DM are strongly associated with adiposopathy, a term that describes the pathophysiological changes of the adipose tissue. In this review, we have highligh...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095867/ https://www.ncbi.nlm.nih.gov/pubmed/37049856 http://dx.doi.org/10.3390/molecules28073094 |
_version_ | 1785024185462947840 |
---|---|
author | Artasensi, Angelica Mazzolari, Angelica Pedretti, Alessandro Vistoli, Giulio Fumagalli, Laura |
author_facet | Artasensi, Angelica Mazzolari, Angelica Pedretti, Alessandro Vistoli, Giulio Fumagalli, Laura |
author_sort | Artasensi, Angelica |
collection | PubMed |
description | Obesity and type 2 diabetes (T2DM) are major public health concerns associated with serious morbidity and increased mortality. Both obesity and T2DM are strongly associated with adiposopathy, a term that describes the pathophysiological changes of the adipose tissue. In this review, we have highlighted adipose tissue dysfunction as a major factor in the etiology of these conditions since it promotes chronic inflammation, dysregulated glucose homeostasis, and impaired adipogenesis, leading to the accumulation of ectopic fat and insulin resistance. This dysfunctional state can be effectively ameliorated by the loss of at least 15% of body weight, that is correlated with better glycemic control, decreased likelihood of cardiometabolic disease, and an improvement in overall quality of life. Weight loss can be achieved through lifestyle modifications (healthy diet, regular physical activity) and pharmacotherapy. In this review, we summarized different effective management strategies to address weight loss, such as bariatric surgery and several classes of drugs, namely metformin, GLP-1 receptor agonists, amylin analogs, and SGLT2 inhibitors. These drugs act by targeting various mechanisms involved in the pathophysiology of obesity and T2DM, and they have been shown to induce significant weight loss and improve glycemic control in obese individuals with T2DM. |
format | Online Article Text |
id | pubmed-10095867 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100958672023-04-13 Obesity and Type 2 Diabetes: Adiposopathy as a Triggering Factor and Therapeutic Options Artasensi, Angelica Mazzolari, Angelica Pedretti, Alessandro Vistoli, Giulio Fumagalli, Laura Molecules Review Obesity and type 2 diabetes (T2DM) are major public health concerns associated with serious morbidity and increased mortality. Both obesity and T2DM are strongly associated with adiposopathy, a term that describes the pathophysiological changes of the adipose tissue. In this review, we have highlighted adipose tissue dysfunction as a major factor in the etiology of these conditions since it promotes chronic inflammation, dysregulated glucose homeostasis, and impaired adipogenesis, leading to the accumulation of ectopic fat and insulin resistance. This dysfunctional state can be effectively ameliorated by the loss of at least 15% of body weight, that is correlated with better glycemic control, decreased likelihood of cardiometabolic disease, and an improvement in overall quality of life. Weight loss can be achieved through lifestyle modifications (healthy diet, regular physical activity) and pharmacotherapy. In this review, we summarized different effective management strategies to address weight loss, such as bariatric surgery and several classes of drugs, namely metformin, GLP-1 receptor agonists, amylin analogs, and SGLT2 inhibitors. These drugs act by targeting various mechanisms involved in the pathophysiology of obesity and T2DM, and they have been shown to induce significant weight loss and improve glycemic control in obese individuals with T2DM. MDPI 2023-03-30 /pmc/articles/PMC10095867/ /pubmed/37049856 http://dx.doi.org/10.3390/molecules28073094 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Artasensi, Angelica Mazzolari, Angelica Pedretti, Alessandro Vistoli, Giulio Fumagalli, Laura Obesity and Type 2 Diabetes: Adiposopathy as a Triggering Factor and Therapeutic Options |
title | Obesity and Type 2 Diabetes: Adiposopathy as a Triggering Factor and Therapeutic Options |
title_full | Obesity and Type 2 Diabetes: Adiposopathy as a Triggering Factor and Therapeutic Options |
title_fullStr | Obesity and Type 2 Diabetes: Adiposopathy as a Triggering Factor and Therapeutic Options |
title_full_unstemmed | Obesity and Type 2 Diabetes: Adiposopathy as a Triggering Factor and Therapeutic Options |
title_short | Obesity and Type 2 Diabetes: Adiposopathy as a Triggering Factor and Therapeutic Options |
title_sort | obesity and type 2 diabetes: adiposopathy as a triggering factor and therapeutic options |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095867/ https://www.ncbi.nlm.nih.gov/pubmed/37049856 http://dx.doi.org/10.3390/molecules28073094 |
work_keys_str_mv | AT artasensiangelica obesityandtype2diabetesadiposopathyasatriggeringfactorandtherapeuticoptions AT mazzolariangelica obesityandtype2diabetesadiposopathyasatriggeringfactorandtherapeuticoptions AT pedrettialessandro obesityandtype2diabetesadiposopathyasatriggeringfactorandtherapeuticoptions AT vistoligiulio obesityandtype2diabetesadiposopathyasatriggeringfactorandtherapeuticoptions AT fumagallilaura obesityandtype2diabetesadiposopathyasatriggeringfactorandtherapeuticoptions |